Página inicial>Investigação clínica>Ensaios clínicos>SeaSTAR

How to use the speech recognition tool?

NCT03772665

SeaSTAR

Safety and Efficacy of Emixustat in Stargardt Disease.

Type: Interventional



Status of the trial: Active, Not recruiting

Orphan Drug Recognition: Yes

Inclusion

  • Opening Date: 2018-11-07
  • Closing Date: 2022-02-01

Criteria

More information

Children: Yes

Adults: Yes

Funder Type: industry

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: